Jan Skvarka

Jan Skvarka

Director/Board Member at ZENTALIS PHARMACEUTICALS, INC.

Net worth: 722 436 $ as of 2024-02-28

57 year
Health Technology
Consumer Services
Commercial Services

Profile

Jan Skvarka occupies the position of Executive Chairman of GentiBio, Inc. and Executive Chairman for DEM BioPharma, Inc. He is also on the board of Zentalis Pharmaceuticals, Inc. and Monte Rosa Therapeutics, Inc. In the past he was President, Chief Executive Officer & Director at Tal Medical, Inc., Partner-Healthcare Practice at Bain & Co., Inc., President, Chief Executive Officer & Director at Trillium Therapeutics ULC and Manager of PricewaterhouseCoopers LLP (United Kingdom).
Dr. Skvarka received an MBA from Harvard Business School and a doctorate from the University of Bratislava Economic.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-09-10 47,970 ( 0.07% ) 715 233 $ 2024-02-28
2023-03-30 1,138 ( 0.00% ) 7 204 $ 2024-02-28

Jan Skvarka active positions

CompaniesPositionStart
ZENTALIS PHARMACEUTICALS, INC. Director/Board Member 2022-09-11
MONTE ROSA THERAPEUTICS, INC. Director/Board Member 2023-03-22
Chairman -
Chairman -
All active positions of Jan Skvarka

Former positions of Jan Skvarka

CompaniesPositionEnd
TRILLIUM THERAPEUTICS Chief Executive Officer 2021-11-16
Corporate Officer/Principal -
Corporate Officer/Principal -
Chief Executive Officer -
See the detail of Jan Skvarka's experience

Training of Jan Skvarka

University of Bratislava Economic Doctorate Degree
Harvard Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jan Skvarka's experience

Connections

68

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
MONTE ROSA THERAPEUTICS, INC.

Health Technology

Private companies7

Health Technology

Health Technology

Commercial Services

Consumer Services

Zentalis Pharmaceuticals, Inc.

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Jan Skvarka